The Use of Methylene Blue during Liver Transplantation for Vasoplegia.
Paul HardingThomas NicholasCale KasselPublished in: Case reports in anesthesiology (2021)
The use of methylene blue for vasoplegia in cardiac cases with cardiopulmonary bypass, septic shock, and acute liver failure is well documented. Use of MB for liver transplantation has been largely limited to case reports. We describe three separate liver transplantation patients with significant hypotension following reperfusion. Administration of methylene blue to each patient resulted in a significant decrease in vasopressor medication and two patients weaned completely. We argue that the use of MB should be considered as a treatment option for refractory hypotension.
Keyphrases
- liver failure
- septic shock
- hepatitis b virus
- end stage renal disease
- case report
- newly diagnosed
- chronic kidney disease
- ejection fraction
- healthcare
- acute myocardial infarction
- prognostic factors
- peritoneal dialysis
- left ventricular
- emergency department
- heart failure
- intensive care unit
- drug induced
- acute respiratory distress syndrome
- acute ischemic stroke
- acute coronary syndrome
- adverse drug
- replacement therapy
- aortic dissection